| EP3209661 - PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.12.2021 Database last updated on 21.03.2026 | |
| Former | The patent has been granted Status updated on 15.01.2021 | ||
| Former | Grant of patent is intended Status updated on 04.10.2020 | ||
| Former | Examination is in progress Status updated on 25.06.2019 | ||
| Former | Request for examination was made Status updated on 28.07.2017 | ||
| Former | The international publication has been made Status updated on 14.04.2017 | Most recent event Tooltip | 06.09.2024 | Lapse of the patent in a contracting state New state(s): MT | published on 09.10.2024 [2024/41] | Applicant(s) | For all designated states Zaklady Farmaceutyczne Polpharma SA Ul. Pelplinska 19 83-200 Starogard Gdanski / PL | [2017/35] | Inventor(s) | 01 /
SAGOL, Karol Ul. Kasztanowa 9c/10 PL-83-110 Tczew / PL | 02 /
KOZIEN-SAJNOG, Magdalena Os. Kalinowe 7/9 PL-31-813 Krakow / PL | [2017/35] | Representative(s) | Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [2021/07] |
| Former [2017/35] | Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | Application number, filing date | 15784372.3 | 22.10.2015 | [2017/35] | WO2015EP74538 | Priority number, date | EP20140460075 | 22.10.2014 Original published format: EP 14460075 | [2017/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016062828 | Date: | 28.04.2016 | Language: | EN | [2016/17] | Type: | A1 Application with search report | No.: | EP3209661 | Date: | 30.08.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.04.2016 takes the place of the publication of the European patent application. | [2017/35] | Type: | B1 Patent specification | No.: | EP3209661 | Date: | 17.02.2021 | Language: | EN | [2021/07] | Search report(s) | International search report - published on: | EP | 28.04.2016 | Classification | IPC: | C07D413/14, C07D333/38, C07D413/12, C07D265/32 | [2020/42] | CPC: |
C07D413/14 (EP,EA,US);
C07D265/32 (EP,EA,US);
C07D333/38 (EP,EA,US);
C07D413/12 (EP,EA,US)
|
| Former IPC [2017/35] | C07D413/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/35] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | VERFAHREN ZUR HERSTELLUNG EINES POLYMORPHS VON RIVAROXABAN | [2020/42] | English: | PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN | [2017/35] | French: | PROCÉDÉ DE PRÉPARATION D'UN POLYMORPHE DE RIVAROXABAN | [2017/35] |
| Former [2017/35] | VERFAHREN ZUR HERSTELLUNG EINES POLYMORPHS AUS RIVAROXABAN | Entry into regional phase | 13.04.2017 | National basic fee paid | 13.04.2017 | Designation fee(s) paid | 13.04.2017 | Examination fee paid | Examination procedure | 13.04.2017 | Examination requested [2017/35] | 13.04.2017 | Date on which the examining division has become responsible | 13.11.2017 | Amendment by applicant (claims and/or description) | 27.06.2019 | Despatch of a communication from the examining division (Time limit: M04) | 03.09.2019 | Reply to a communication from the examining division | 14.01.2020 | Despatch of a communication from the examining division (Time limit: M04) | 22.05.2020 | Reply to a communication from the examining division | 05.10.2020 | Communication of intention to grant the patent | 11.01.2021 | Fee for grant paid | 11.01.2021 | Fee for publishing/printing paid | 11.01.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 18.11.2021 | No opposition filed within time limit [2022/04] | Fees paid | Renewal fee | 15.12.2017 | Renewal fee patent year 03 | 18.10.2018 | Renewal fee patent year 04 | 21.08.2019 | Renewal fee patent year 05 | 02.11.2020 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.10.2017 | 03   M06   Fee paid on   15.12.2017 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 22.10.2015 | AL | 17.02.2021 | AT | 17.02.2021 | CY | 17.02.2021 | CZ | 17.02.2021 | DK | 17.02.2021 | EE | 17.02.2021 | ES | 17.02.2021 | FI | 17.02.2021 | HR | 17.02.2021 | IT | 17.02.2021 | LT | 17.02.2021 | LV | 17.02.2021 | MC | 17.02.2021 | MK | 17.02.2021 | MT | 17.02.2021 | NL | 17.02.2021 | RO | 17.02.2021 | RS | 17.02.2021 | SE | 17.02.2021 | SI | 17.02.2021 | SK | 17.02.2021 | SM | 17.02.2021 | TR | 17.02.2021 | BG | 17.05.2021 | NO | 17.05.2021 | GR | 18.05.2021 | IS | 17.06.2021 | PT | 17.06.2021 | GB | 22.10.2021 | IE | 22.10.2021 | LU | 22.10.2021 | BE | 31.10.2021 | CH | 31.10.2021 | FR | 31.10.2021 | LI | 31.10.2021 | [2024/41] |
| Former [2024/29] | HU | 22.10.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| MK | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| TR | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| IE | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2024/22] | HU | 22.10.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| MK | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| IE | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2023/30] | HU | 22.10.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CY | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| IE | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2023/29] | HU | 22.10.2015 | |
| AL | 17.02.2021 | ||
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| IE | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2022/48] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| IE | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2022/41] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| FR | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2022/37] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| CH | 31.10.2021 | ||
| LI | 31.10.2021 | ||
| Former [2022/35] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| GB | 22.10.2021 | ||
| LU | 22.10.2021 | ||
| BE | 31.10.2021 | ||
| Former [2022/33] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| MC | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| BE | 31.10.2021 | ||
| Former [2022/23] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| IT | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2022/13] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SI | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2022/10] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2022/08] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| ES | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2022/07] | AL | 17.02.2021 | |
| AT | 17.02.2021 | ||
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/50] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RO | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SK | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/49] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| DK | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/48] | AT | 17.02.2021 | |
| CZ | 17.02.2021 | ||
| EE | 17.02.2021 | ||
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/46] | AT | 17.02.2021 | |
| FI | 17.02.2021 | ||
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| SM | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/42] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| IS | 17.06.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/38] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| NL | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| SE | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/37] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| LV | 17.02.2021 | ||
| RS | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/36] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| BG | 17.05.2021 | ||
| NO | 17.05.2021 | ||
| GR | 18.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/35] | FI | 17.02.2021 | |
| HR | 17.02.2021 | ||
| LT | 17.02.2021 | ||
| NO | 17.05.2021 | ||
| PT | 17.06.2021 | ||
| Former [2021/33] | FI | 17.02.2021 | |
| LT | 17.02.2021 | ||
| NO | 17.05.2021 | ||
| PT | 17.06.2021 | Cited in | International search | [A] WO2011012321 (KRKA D D NOVO MESTO et al.) | [AD] WO2007039132 (BAYER HEALTHCARE AG et al.) | [A] WO2014096214 (FARMA GRS D O O et al.) | [AD] WO2015111076 (SYMED LABS LTD et al.) [AD] 1-15 * the whole document * | [A] "Crystalline form of 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride and crystalline forms of S-enantiomer and of racemic 5-Chloro-N-({2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 5 August 2010 (2010-08-05), XP013143681, ISSN: 1533-0001 | [A] ANIL C MALI ET AL: "Facile approach for the synthesis of rivaroxaban using alternate synthon: reaction, crystallization and isolation in single pot to achieve desired yield, quality and crystal form", SUSTAINABLE CHEMICAL PROCESSES, vol. 48, no. 1, 13 July 2015 (2015-07-13), pages 5900, XP055230109, DOI: 10.1186/s40508-015-0036-3 DOI: http://dx.doi.org/10.1186/s40508-015-0036-3 | by applicant | WO0147949 | WO2004060887 | WO2007039132 | WO2005068456 |